Episode 414: CoQ10, Longevity, and Heart Health
Heart Doc VIP with Dr. Joel Kahn
Insights into Cardiovascular Drug Research and Findings
This chapter explores the SCORD trial, a significant study involving over 10,000 diabetes and kidney disease patients that assessed the impact of sodagliflozin. It also discusses ongoing research on lipoprotein A and an innovative injectable drug by Amgen, shedding light on new cardiovascular treatment avenues.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
